{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:39:06Z","timestamp":1793176746072,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.hrthm.2026.04.050","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:48:19Z","timestamp":1777942099000},"page":"e2814-e2824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global research trends in cancer-associated atrial fibrillation: A bibliometric analysis of the cardio-oncology interface"],"prefix":"10.1016","volume":"23","author":[{"given":"Zongrong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8081-2484","authenticated-orcid":false,"given":"Zhenyang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.04.050_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/CM9.0000000000003419","article-title":"Cardiovascular diseases in patients with cancer: A comprehensive review of epidemiological trends, cardiac complications, and prognostic implications","volume":"138","author":"Alshahrani","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.hrthm.2026.04.050_bib2","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMra1712502","article-title":"Cancer survivorship","volume":"379","author":"Shapiro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.04.050_bib3","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.hrthm.2026.04.050_bib4","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1093\/ehjci\/jeac030","volume":"24","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2026.04.050_bib5","doi-asserted-by":"crossref","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","article-title":"Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association","volume":"139","author":"Gilchrist","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.050_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.050_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15420\/ecr.2017:17:2","article-title":"Cardio-oncology: a focus on cardiotoxicity","volume":"13","author":"Koutsoukis","year":"2018","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.36660\/abc.20201362","article-title":"Screening, diagnosis and management of atrial fibrillation in cancer patients: current evidence and future perspectives","volume":"119","author":"Gon\u00e7alves-Teixeira","year":"2022","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/00325481.2023.2218188","article-title":"Safety of catheter ablation for atrial fibrillation in patients with cancer: a nationwide cohort study","volume":"135","author":"Thotamgari","year":"2023","journal-title":"Postgrad Med"},{"key":"10.1016\/j.hrthm.2026.04.050_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaccao.2021.08.011","article-title":"Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Leiva","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib11","first-page":"29","article-title":"Atrial fibrillation in cancer survivors - a systematic review and meta-analysis","volume":"9","author":"Bao","year":"2023","journal-title":"Cardiooncology"},{"key":"10.1016\/j.hrthm.2026.04.050_bib12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.amjcard.2015.01.540","article-title":"Relation between cancer and atrial fibrillation (from the REasons for Geographic and Racial Differences in Stroke Study)","volume":"115","author":"O\u2019Neal","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cvr\/cvy272","article-title":"The prothrombotic state in atrial fibrillation: pathophysiological and management implications","volume":"115","author":"Khan","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2026.04.050_bib14","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.3390\/jcm13247753","article-title":"Atrial fibrillation and cancer-epidemiology, mechanisms, and management","volume":"13","author":"Davis","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrthm.2026.04.050_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11886-025-02261-4","article-title":"Diagnosis and management of atrial arrhythmias in cancer patients","volume":"27","author":"Monsour","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hrthm.2026.04.050_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jamacardio.2016.0280","article-title":"Risk of malignant cancer among women with new-onset atrial fibrillation","volume":"1","author":"Conen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.breast.2019.05.017","article-title":"Current status of anticoagulation in patients with breast cancer and atrial fibrillation","volume":"46","author":"Pardo Sanz","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.hrthm.2026.04.050_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ehjqcco\/qcad077","article-title":"Clinical outcomes in hospitalized patients with cancer and new versus preexistent atrial fibrillation","volume":"10","author":"Kosmidou","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.hrthm.2026.04.050_bib19","article-title":"The mysterious association between atrial fibrillation and cancer: A literature review","volume":"15","author":"Miqdad","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.hrthm.2026.04.050_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/eurjpc\/zwaa054","article-title":"Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management","volume":"28","author":"Boriani","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.hrthm.2026.04.050_bib21","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.thromres.2022.01.001","article-title":"Optimizing antithrombotic therapy for atrial fibrillation in cancer","volume":"213","author":"Tufano","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.hrthm.2026.04.050_bib22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2018.07.077","article-title":"Provider specialty, anticoagulation, and stroke risk in patients with atrial fibrillation and cancer","volume":"72","author":"O\u2019Neal","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.athoracsur.2010.03.100","article-title":"Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database","volume":"90","author":"Onaitis","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hrthm.2026.04.050_bib24","article-title":"Commentary: bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40249-016-0182-1","article-title":"Bibliometric study of research and development for neglected diseases in the BRICS","volume":"5","author":"Bai","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.hrthm.2026.04.050_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clinimag.2022.02.024","article-title":"Bibliometric analysis of interventional radiology studies in PubMed-indexed literature from 1991 to 2020","volume":"85","author":"Gowda","year":"2022","journal-title":"Clin Imaging"},{"key":"10.1016\/j.hrthm.2026.04.050_bib27","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3324\/haematol.2017.171041","article-title":"Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials","volume":"102","author":"Brown","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.hrthm.2026.04.050_bib28","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","article-title":"Insights into onco-cardiology: atrial fibrillation in cancer","volume":"63","author":"Farmakis","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3892\/ol.2022.13244","article-title":"Anticoagulation for atrial fibrillation in active cancer","volume":"23","author":"Farmakis","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.hrthm.2026.04.050_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100096","article-title":"Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice","volume":"7","author":"Chu","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.hrthm.2026.04.050_bib31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/bjh.14324","article-title":"Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study","volume":"175","author":"Thompson","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib32","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/medicina61101815","article-title":"Cardiac surgery and postoperative atrial fibrillation: the role of cancer","volume":"61","author":"Georghiou","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.hrthm.2026.04.050_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11936-014-0312-7","article-title":"Cardiac complications of chemotherapy: role of prevention","volume":"16","author":"Magnano","year":"2014","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.04.050_bib34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jtcvs.2003.07.011","article-title":"Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients","volume":"127","author":"Vaporciyan","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hrthm.2026.04.050_bib35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5603\/CJ.2012.0084","article-title":"5-fluorouracil induced cardiotoxicity: review of the literature","volume":"19","author":"Sorrentino","year":"2012","journal-title":"Cardiol J"},{"issue":"Suppl 5","key":"10.1016\/j.hrthm.2026.04.050_bib36","doi-asserted-by":"crossref","first-page":"v277","DOI":"10.1093\/annonc\/mdq200","article-title":"Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines","volume":"21","author":"Bovelli","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hrthm.2026.04.050_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/bloodadvances.2017010694","article-title":"Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation","volume":"2","author":"Shah","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.hrthm.2026.04.050_bib38","first-page":"0509","article-title":"Ibrutinib promotes atrial fibrillation by disrupting A-kinase anchoring protein 1-mediated mitochondrial quality surveillance in cardiomyocytes","volume":"7","author":"Li","year":"2024","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.hrthm.2026.04.050_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.31083\/j.rcm2410296","article-title":"Machine learning in cardio-oncology: new insights from an emerging discipline","volume":"24","author":"Zheng","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.04.050_bib40","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/jcm13051313","article-title":"Many models, little adoption-what accounts for low uptake of machine learning models for atrial fibrillation prediction and detection?","volume":"13","author":"Kawamura","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrthm.2026.04.050_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1434963","article-title":"Bidirectional two-sample Mendelian randomization study of atrial fibrillation and breast cancer","volume":"11","author":"Ding","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"suppl 2","key":"10.1016\/j.hrthm.2026.04.050_bib42","first-page":"S44","article-title":"Atrial fibrillation and bleeding in patients with chronic lymphocytic leukemia treated with ibrutinib in the Veterans Health Administration","volume":"37","author":"Rasmussen","year":"2020","journal-title":"Fed Pract"},{"key":"10.1016\/j.hrthm.2026.04.050_bib43","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11886-022-01769-3","article-title":"Atrial fibrillation and cancer patients: mechanisms and management","volume":"24","author":"Madnick","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hrthm.2026.04.050_bib44","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.21037\/tcr-24-2107","article-title":"Causal associations between atrial fibrillation and esophageal cancer: a two-sample Mendelian randomization study","volume":"14","author":"Lei","year":"2025","journal-title":"Transl Cancer Res"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126023398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126023398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:25:08Z","timestamp":1793175908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126023398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1547527126023398"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.04.050","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global research trends in cancer-associated atrial fibrillation: A bibliometric analysis of the cardio-oncology interface","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}